Circus SE receives official supplier certification for U.S. government institutions and the Department of Defense
The certification grants Circus access to U.S. federal procurement programs and contracts, including those of the Department of Defense and global U.S. military, marking a key milestone in the company's international expansion strategy.
As the first AI-robotics player in the global food-service sector to achieve this highly regulated status, Circus is now positioned to participate in federal supply contracts across military and government agencies. This regulatory clearance accelerates the strategic deployment of its autonomous, AI-powered cooking systems, CA-1 and CA-M, within U.S. defense initiatives and dual-use technology programs.
"This approval unlocks the next stage in executing our international strategy in the defense and public sector," says Nikolas Bullwinkel, CEO and Founder of Circus SE. "It confirms our operational maturity, strengthens our geopolitical presence, and opens the door to high-impact, security-critical applications."
Following the recent appointment of Sasha Borovik as General Counsel, formerly head lawyer for Microsoft's global public sector business, Circus further strengthens its US market access and public sector capabilities. The certification positions Circus as a trusted partner for government institutions and paves the way for long-term contracts, and global defense collaborations.
About Circus SE
Circus SE (XETRA: CA1) is a global AI and robotics company developing autonomous systems for food supply in both civilian and defense sectors. Its flagship robot, the patented CA-1, is the world's first fully autonomous food production robot, now in serial production. Powered by proprietary embodied AI, Circus delivers industrial-scale, high-reliability meal output with minimal human input. Headquartered in Munich, the company is building the global infrastructure for autonomous food supply — on a mission to fuel humanity.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
IBM Stock Downgraded to $310 Target — But Bank of America Still Says Buy
International Business Machines Corporation (NYSE:IBM) is one of the . On July 24, Bank of America reiterated the stock as 'Buy' and lowered the firm's price target on IBM (IBM) to $310 from $320 following a 'mixed quarter.' The bank said that IBM is well-positioned for growth following its most recent financial report. The company reported adjusted earnings per share of $2.80 for the quarter, beating the LSEG estimate of $2.64. Meanwhile, revenue came in at $16.98 billion, ahead of the expected $16.59 billion. 'IBM reported a mixed quarter, where organic software deceleration was offset by strong contribution from better-than-expected Infrastructure results and higher M & A contribution.' A closeup of a woman's hands typing rapidly on a laptop in a corporate office setting. The firm believes that, post-earnings, IBM has turned into a 'show me' story on software in the second half of the year, but remains bullish on the overall company trajectory. The analysts further stated that they believe estimates will move higher this year and next year, 'with increasing contribution from high-margin software.' International Business Machines Corporation (NYSE:IBM) is a multinational technology company and a pioneer in artificial intelligence, offering AI consulting services and a suite of AI software products. While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
IBM Stock Downgraded to $310 Target — But Bank of America Still Says Buy
International Business Machines Corporation (NYSE:IBM) is one of the . On July 24, Bank of America reiterated the stock as 'Buy' and lowered the firm's price target on IBM (IBM) to $310 from $320 following a 'mixed quarter.' The bank said that IBM is well-positioned for growth following its most recent financial report. The company reported adjusted earnings per share of $2.80 for the quarter, beating the LSEG estimate of $2.64. Meanwhile, revenue came in at $16.98 billion, ahead of the expected $16.59 billion. 'IBM reported a mixed quarter, where organic software deceleration was offset by strong contribution from better-than-expected Infrastructure results and higher M & A contribution.' A closeup of a woman's hands typing rapidly on a laptop in a corporate office setting. The firm believes that, post-earnings, IBM has turned into a 'show me' story on software in the second half of the year, but remains bullish on the overall company trajectory. The analysts further stated that they believe estimates will move higher this year and next year, 'with increasing contribution from high-margin software.' International Business Machines Corporation (NYSE:IBM) is a multinational technology company and a pioneer in artificial intelligence, offering AI consulting services and a suite of AI software products. While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Yahoo
12 hours ago
- Yahoo
1&1's (ETR:1U1) Returns On Capital Not Reflecting Well On The Business
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Although, when we looked at 1&1 (ETR:1U1), it didn't seem to tick all of these boxes. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Understanding Return On Capital Employed (ROCE) For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on 1&1 is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.07 = €546m ÷ (€8.4b - €680m) (Based on the trailing twelve months to March 2025). Therefore, 1&1 has an ROCE of 7.0%. In absolute terms, that's a low return and it also under-performs the Wireless Telecom industry average of 9.0%. Check out our latest analysis for 1&1 Above you can see how the current ROCE for 1&1 compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for 1&1 . The Trend Of ROCE On the surface, the trend of ROCE at 1&1 doesn't inspire confidence. To be more specific, ROCE has fallen from 13% over the last five years. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line. The Bottom Line On 1&1's ROCE To conclude, we've found that 1&1 is reinvesting in the business, but returns have been falling. Since the stock has declined 16% over the last five years, investors may not be too optimistic on this trend improving either. All in all, the inherent trends aren't typical of multi-baggers, so if that's what you're after, we think you might have more luck elsewhere. One more thing to note, we've identified 2 warning signs with 1&1 and understanding these should be part of your investment process. While 1&1 isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
